In this review we discuss the recent approaches using different immunological components to treat MM.
This review focuses on contemporary developments of mucosal vaccination approaches using different routes of administration.
Several tissue engineering approaches using different cell types and hydrogels/scaffolds have been proposed.
The approaches use different values for stress cpu threshold: Energy-Reduction uses 95% and SLAV-Reduction uses 85%.
We demonstrate that the two approaches use different metrics for measuring success and frequently lead to quite different insights and strategic decisions.
However, current approaches using different lipid membrane models usually are time-consuming or show severe experimental drawbacks.
Single path (SP) routing approaches using different schemes have been proposed as TE approaches for energy efficient communication in wireless networks.
Noncovalent approaches use different types of functionalization agents involving polymers, poly nuclear aromatic compounds, surfactants, and biomolecules for the noncovalent dispersion of carbon nanotubes (Reddy et al. 2009).
Our three approaches use different sets of data features (although SSS uses of all of them).
Second, studies that network approaches use different definitions for weight and different normalization schemes complicating the comparison between studies.
